Pure Global

Myo Rapid Quantitative Test - India CDSCO Medical Device Registration

Myo Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000395_5402c1da55540d1cb9c6be8c83a04c00_896dedf7e9c64dc5716c303d961519b2. This device is marketed under the brand name Biotime . The license holder is M/s Vishat Diagnostic Pvt Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Myo Rapid Quantitative Test
UID: IMP/IVD/2021/000395_5402c1da55540d1cb9c6be8c83a04c00_896dedf7e9c64dc5716c303d961519b2

Brand Name

Biotime

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime MYO (Biotime ) Rapid Quantitative Test is intended to quantify the concentration of MYO in human serum or plasma on Biotime FIA Analyzers by fluorescent immunoassay. It is used as an aid detection of acute myocardial infarction

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing